Will The $86m Stelis-Syngene Deal Change India’s Biologics Landscape?

Acquired Plant Seen Operational In 2024

 
• By Vibha Ravi
Indian Vaccine Deal
A Handshake To Change India's Biologics Landscape? • Source: Shutterstock

More from Business

More from Scrip